Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pascorbin as add-on therapy in acute herpes zoster: randomized double-blind placebo-controlled 4-arm pilot trial
2018-002387-86Phase 2Terminated
- Sponsor
- Pascoe
- Start
- Sep 2019
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of C-vimin in herpes zoster (HZ) (4 arms), sponsored by Pascoe. Primary endpoints: Area under the curve (AUC) of mean neuropathic pain and Comparison of efficacy and tolerability of three Pascorbin doses versus placebo. Started Sep 2019; status: terminated.
02
Drugs
C-vimin
03
Conditions
herpes zoster (HZ)
Beyond the preview
Go deeper on 2018-002387-86.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2018-002387-86.